{"id":450567,"date":"2021-03-04T08:03:35","date_gmt":"2021-03-04T13:03:35","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=450567"},"modified":"2021-03-04T08:03:35","modified_gmt":"2021-03-04T13:03:35","slug":"f-star-therapeutics-to-present-at-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/f-star-therapeutics-to-present-at-upcoming-investor-conferences\/","title":{"rendered":"F-star Therapeutics to Present at Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., March  04, 2021  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ENpCGZd4EvHHfz1tRPcGXfoqo_ztvDVsFE9MFtk5TwZTgz87Q8zUIR5sRKQhvOyaCqQoP-u-M-AgKanPBNaMdl8pZKzMcz9ink_orspnMkA=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">F-star Therapeutics, Inc.<\/a> (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing next generation immunotherapies to transform the lives of patients with cancer, today announced that the company\u2019s management team will participate in the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HC7YoAKCmPWowZvTctYMi20_pVAocOpYG_xVbAbauUldvQTufCUesf_0-G6_WEZn3cfCdI8sr6uGhAqf3f3xkDpsKMqKhO2gt1PsnArQYhU20OXuq_5SSgzIuO8XKikwS35i99yNxT5UfLhGohNdiSsJ1YjmF3w-zSi_PuJzQog=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">H.C. Wainwright Global Life Science Conference<\/a> and the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=sMTCZJtYBsmVGzTid8xjwPxu9cuBj-gOo6b7tEG5jEOnH7ipw4vYRAjusjFcFqPT1IGWUh1pVHX74YvPuHK77ftWR67Pf405EVCR8Ugg272G4e5_bSiUUEhL9nL-O4OW0tHQWypdqvKfJfQnoDHs5sNEf0Uo1jsJe_zocdVuv8YfJSvDzpvvb1WpMgSAh1eQmXChj-mnBeadDVpsWC0DCw==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Oppenheimer &amp; Co 31st Annual Healthcare Conference<\/a>. Both events will take place virtually.<\/p>\n<p>Details are as follows:<\/p>\n<p align=\"justify\">\n        <strong>H.C. Wainwright Global Life Science Conference <\/strong>(March 9-10, 2021)<\/p>\n<p>Fireside chat with F-star CEO, Eliot Forster<\/p>\n<p>Date: March 9, 2021<\/p>\n<p>Time: 7:00am EST<\/p>\n<p>\n        <strong>Oppenheimer &amp; Co 31<\/strong><br \/>\n        <sup><br \/>\n          <strong>st<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Healthcare Conference<\/strong> (March 16-18, 2021)<\/p>\n<p>Fireside chat with F-star CEO, Eliot Forster<\/p>\n<p>Date: March 17, 2021<\/p>\n<p>Time: 8:00am EST<\/p>\n<p>Replay will be available at: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=S838iKwn6N6c9r-cxQsLzPbNOPt-baZ9qJiOevrVo-ibWPt1hTzEwG3bFu8sZSRfdQiGEd8Di0wwyo4Ylu6mbFhVfuWxjUpSzE1ijWWiFvZj1lN8k-7bOHOvnfTUHSP4gVHQ2f_lNE4FauHpBCrH80XlESjO17c5y9qEr6_odC6fsuleSx-utmkQ8qkt1qxQ\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/wsw.com\/webcast\/oppenheimer9\/fstar\/2958208<\/a> for 90 days following the conference.<\/p>\n<p>\n        <strong>Eliot Forster, CEO of F-star Therapeutics, Inc., said<\/strong>: \u201cIt has been a busy start to the year, having listed on NASDAQ at the end of 2020, and we look forward to sharing our business strategy and updates on our four clinical programs. We are particularly looking forward to presenting our most recent updates on FS120 and FS222 (both targeting CD137). These two programs, and our other next-generation immunotherapies, have significant potential to transform the lives of patients with cancer.\u201d<\/p>\n<p>\n        <strong>About F-star Therapeutics, Inc.<\/strong>\n      <\/p>\n<p>F-star is a clinical-stage biopharmaceutical company developing tetravalent bispecific antibodies for a paradigm-shift in cancer therapy. By developing medicines that seek to block tumor immune evasion, the Company\u2019s goal is to offer patients greater and more durable benefits than current immuno-oncology treatments. Through its proprietary tetravalent, bispecific natural antibody (mAb\u00b2\u2122) format, F-star\u2019s mission is to generate highly differentiated best-in-class drug candidates with monoclonal antibody-like manufacturability. For more information visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=aXW6m_NTMrN-gG63ZqGpbSZkbjaGVn8nobVfQLd9lmCXh0towyU3sgyOJZnZ5-pICw8LXSVzdef0lnZ7Gblo6A==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.f-star.com<\/a> and follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=J_DptgMsHOTC2HvVVj0kNK3-DNSVyuctG7HN-bBaqMkVTrtlry94u2Y_A0pEb8LC0L4OedJmcPFIjd8Go77vSMa4yyei3y6eeQCz_ZFqZPzBizoLgYN1s6mVhEwrD1LQ\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">LinkedIn<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fNkiDwVN8Uaark6joMpa5OADQc7wSEQzA7CDlk6jxo3kOxVeWZXEIpIZs2rBslIMwpQMNUe8DcFaiT3CoUE6zcCBb8BkEzlQywy1nyGv02g=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Twitter<\/a>.<\/p>\n<p>\n        <strong>For further information, please contact:<\/strong>\n      <\/p>\n<p>\n        <strong>For investor inquiries<br \/><\/strong><br \/>\n        <strong>Lindsey Trickett<br \/><\/strong>VP Investor Relations &amp; Communications<br \/>+1 240 543 7970<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ecQLcWw1B2-Iv-yZOI2I2I5jsUjSmEENjL9PKLhdhdohOtYWzRcAR2wgoIWxvFXWYaksW_0nDGutZkdh_SLEPauS7ltnraeTIkQjGHhzZXF4V5Okipf8Q1QmLR8OoKyi\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">lindsey.trickett@f-star.com<\/a><\/p>\n<p>\n        <strong>For media inquiries<br \/><\/strong><br \/>\n        <strong>Helen Shik<br \/><\/strong>Shik Communications LLC<br \/>617-510-4373<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=boQV_zZ97myBZeW8Gy1yXqYPR09l00mRjXbVWtpSooZdVJLgAXAFa_DfG89zdVHeVoVcCj62bUtQNBc8cTum4BqP_eI2sZT0cWSFlN_R7-M=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Shik.Helen10@gmail.com<\/a><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDEyOSM0MDQ3MzM4IzIyMDI3NjA=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/0f3b4488-acde-4560-b214-8c04d101849a\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., March 04, 2021 (GLOBE NEWSWIRE) &#8212; F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing next generation immunotherapies to transform the lives of patients with cancer, today announced that the company\u2019s management team will participate in the H.C. Wainwright Global Life Science Conference and the Oppenheimer &amp; Co 31st Annual Healthcare Conference. Both events will take place virtually. Details are as follows: H.C. Wainwright Global Life Science Conference (March 9-10, 2021) Fireside chat with F-star CEO, Eliot Forster Date: March 9, 2021 Time: 7:00am EST Oppenheimer &amp; Co 31 st Annual Healthcare Conference (March 16-18, 2021) Fireside chat with F-star CEO, Eliot Forster Date: March 17, 2021 Time: 8:00am EST Replay &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/f-star-therapeutics-to-present-at-upcoming-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;F-star Therapeutics to Present at Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-450567","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>F-star Therapeutics to Present at Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/f-star-therapeutics-to-present-at-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"F-star Therapeutics to Present at Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., March 04, 2021 (GLOBE NEWSWIRE) &#8212; F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing next generation immunotherapies to transform the lives of patients with cancer, today announced that the company\u2019s management team will participate in the H.C. Wainwright Global Life Science Conference and the Oppenheimer &amp; Co 31st Annual Healthcare Conference. Both events will take place virtually. Details are as follows: H.C. Wainwright Global Life Science Conference (March 9-10, 2021) Fireside chat with F-star CEO, Eliot Forster Date: March 9, 2021 Time: 7:00am EST Oppenheimer &amp; Co 31 st Annual Healthcare Conference (March 16-18, 2021) Fireside chat with F-star CEO, Eliot Forster Date: March 17, 2021 Time: 8:00am EST Replay &hellip; Continue reading &quot;F-star Therapeutics to Present at Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/f-star-therapeutics-to-present-at-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-04T13:03:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDEyOSM0MDQ3MzM4IzIyMDI3NjA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/f-star-therapeutics-to-present-at-upcoming-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/f-star-therapeutics-to-present-at-upcoming-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"F-star Therapeutics to Present at Upcoming Investor Conferences\",\"datePublished\":\"2021-03-04T13:03:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/f-star-therapeutics-to-present-at-upcoming-investor-conferences\\\/\"},\"wordCount\":333,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/f-star-therapeutics-to-present-at-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NDEyOSM0MDQ3MzM4IzIyMDI3NjA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/f-star-therapeutics-to-present-at-upcoming-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/f-star-therapeutics-to-present-at-upcoming-investor-conferences\\\/\",\"name\":\"F-star Therapeutics to Present at Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/f-star-therapeutics-to-present-at-upcoming-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/f-star-therapeutics-to-present-at-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NDEyOSM0MDQ3MzM4IzIyMDI3NjA=\",\"datePublished\":\"2021-03-04T13:03:35+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/f-star-therapeutics-to-present-at-upcoming-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/f-star-therapeutics-to-present-at-upcoming-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/f-star-therapeutics-to-present-at-upcoming-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NDEyOSM0MDQ3MzM4IzIyMDI3NjA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NDEyOSM0MDQ3MzM4IzIyMDI3NjA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/f-star-therapeutics-to-present-at-upcoming-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"F-star Therapeutics to Present at Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"F-star Therapeutics to Present at Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/f-star-therapeutics-to-present-at-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"F-star Therapeutics to Present at Upcoming Investor Conferences - Market Newsdesk","og_description":"CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., March 04, 2021 (GLOBE NEWSWIRE) &#8212; F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing next generation immunotherapies to transform the lives of patients with cancer, today announced that the company\u2019s management team will participate in the H.C. Wainwright Global Life Science Conference and the Oppenheimer &amp; Co 31st Annual Healthcare Conference. Both events will take place virtually. Details are as follows: H.C. Wainwright Global Life Science Conference (March 9-10, 2021) Fireside chat with F-star CEO, Eliot Forster Date: March 9, 2021 Time: 7:00am EST Oppenheimer &amp; Co 31 st Annual Healthcare Conference (March 16-18, 2021) Fireside chat with F-star CEO, Eliot Forster Date: March 17, 2021 Time: 8:00am EST Replay &hellip; Continue reading \"F-star Therapeutics to Present at Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/f-star-therapeutics-to-present-at-upcoming-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-04T13:03:35+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDEyOSM0MDQ3MzM4IzIyMDI3NjA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/f-star-therapeutics-to-present-at-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/f-star-therapeutics-to-present-at-upcoming-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"F-star Therapeutics to Present at Upcoming Investor Conferences","datePublished":"2021-03-04T13:03:35+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/f-star-therapeutics-to-present-at-upcoming-investor-conferences\/"},"wordCount":333,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/f-star-therapeutics-to-present-at-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDEyOSM0MDQ3MzM4IzIyMDI3NjA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/f-star-therapeutics-to-present-at-upcoming-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/f-star-therapeutics-to-present-at-upcoming-investor-conferences\/","name":"F-star Therapeutics to Present at Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/f-star-therapeutics-to-present-at-upcoming-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/f-star-therapeutics-to-present-at-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDEyOSM0MDQ3MzM4IzIyMDI3NjA=","datePublished":"2021-03-04T13:03:35+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/f-star-therapeutics-to-present-at-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/f-star-therapeutics-to-present-at-upcoming-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/f-star-therapeutics-to-present-at-upcoming-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDEyOSM0MDQ3MzM4IzIyMDI3NjA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDEyOSM0MDQ3MzM4IzIyMDI3NjA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/f-star-therapeutics-to-present-at-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"F-star Therapeutics to Present at Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/450567","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=450567"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/450567\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=450567"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=450567"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=450567"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}